Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001214659-13-003903
Filing Date
2013-07-15
Accepted
2013-07-15 16:30:15
Documents
1
Period of Report
2013-07-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-18834.html 3  
1 PRIMARY DOCUMENT marketforms-18834.xml 3 7485
  Complete submission text file 0001214659-13-003903.txt   10018
Mailing Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121
Business Address
TANG KEVIN C (Reporting) CIK: 0001178579 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35921 | Film No.: 13968522

Mailing Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121 858-200-3830
TANG CAPITAL PARTNERS LP (Reporting) CIK: 0001191935 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35921 | Film No.: 13968524

Mailing Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121 858-200-3830
TANG CAPITAL MANAGEMENT LLC (Reporting) CIK: 0001232621 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35921 | Film No.: 13968523

Mailing Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 (514) 337-3333
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

EIN.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations